Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Voriconazol versus anfotericina B o fluconazol en pacientes oncológicos con neutropenia

Información

DOI:
https://doi.org/10.1002/14651858.CD004707.pub3Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 24 febrero 2014see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Cáncer ginecológico, neurooncología y otros cánceres

Copyright:
  1. Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Karsten Juhl Jørgensen

    Correspondencia a: Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark

    [email protected]

  • Peter C Gøtzsche

    Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark

  • Christina S Dalbøge

    Department of Clinical Microbiology, Rigshospitalet, Copenhagen Ø, Denmark

  • Helle Krogh Johansen

    Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark

Contributions of authors

HKJ and PCG conceived the project. HKJ, PCG and KJJ contributed to the development of the protocol and the first version of the review. HKJ, KJJ and CSD performed the data extraction. The draft for the updated review (January 2014) was written by CSD and revised by KJJ, HKJ and PCG.

Sources of support

Internal sources

  • Copenhagen Hospital Corporation, Denmark

External sources

  • No sources of support supplied

Declarations of interest

We certify that we have no affiliations with or involvement in any organisation or entity with a direct financial interest in the subject matter of the review (for example employment, consultancy, stock ownership, honoraria, expert testimony).

Acknowledgements

We would like to thank Dr Peter F Troke, Pfizer, for additional information on the trials sponsored by the company.

The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Gynaecological Cancer Group.

The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the NIHR, NHS or the Department of Health.

Version history

Published

Title

Stage

Authors

Version

2014 Feb 24

Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia

Review

Karsten Juhl Jørgensen, Peter C Gøtzsche, Christina S Dalbøge, Helle Krogh Johansen

https://doi.org/10.1002/14651858.CD004707.pub3

2006 Jan 25

Voriconazole versus amphotericin B in cancer patients with neutropenia

Review

Karsten Juhl Jørgensen, Peter C Gøtzsche, Helle Krogh Johansen

https://doi.org/10.1002/14651858.CD004707.pub2

2004 Apr 19

Voriconazole versus amphotericin B and fluconazole in cancer patients with neutropenia

Protocol

KJ Jørgensen, PC Gøtzsche, HK Johansen

https://doi.org/10.1002/14651858.CD004707

Differences between protocol and review

We did not report on colonisation as there were no data on this in the included trials, nor on total number of dropouts as the trials were flawed by design, rendering such data meaningless.

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Humans;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.